US/China-based MicuRx Gets $55m Series C Funding For MRX-I Antibiotic

 
• By Sten Stovall
  
US-Money-and-Pills_V2_1200x675
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia